MediciNova Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | 100.0% | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.3% | – | 0.0% | – | – | – | – | – | – | 0.6% | – | – | – | – | – | – | 86.4% | 93.5% | 65.9% | 93.2% | 30.7% | 57.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 100.0% | -0.3% | 100.0% | 0.0% | – | – | – | – | – | – | 100.0% | – | – | – | – | – | – | 13.6% | 6.5% | 34.1% | 6.8% | 69.3% | 42.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 50.8% | 132.8% | 5,340.3% | 0.0% | – | – | – | – | – | – | 70.2% | – | – | – | – | – | – | 1,514.6% | 1,234.2% | 1,114.0% | 675,198.9% | 224.5% | 137,618.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 51.4% | 100.0% | 3,981.4% | 0.0% | – | – | – | – | – | – | 128.8% | – | – | – | – | – | – | 1,026.2% | 1,425.1% | 1,024.0% | 850,433.7% | 399.1% | 173,313.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 105.0% | 241.8% | 9,705.2% | 0.1% | – | – | – | – | – | – | 214.7% | – | – | – | – | – | – | 2,693.4% | 2,748.2% | 2,072.1% | 1,523.4% | 623.6% | 1,329.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -5.0% | -241.8% | -9,605.2% | -0.1% | – | – | – | – | – | – | -114.7% | – | – | – | – | – | – | -2,679.9% | -2,741.7% | -2,038.0% | -1,516.6% | -554.3% | -1,287.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -4.7% | -240.4% | -9,544.4% | -0.1% | – | – | – | – | – | – | -72.3% | – | – | – | – | – | – | -2,437.7% | -2,473.6% | -1,842.8% | -1,383.1% | -504.8% | -1,167.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -0.9% | -1.9% | -96.4% | 0.0% | – | – | – | – | – | – | -114,618.5% | – | – | – | – | – | – | – | – | 4.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -4.7% | -240.4% | -9,544.4% | -0.1% | – | – | – | – | – | – | -72.3% | – | – | – | – | – | – | -2,437.7% | -2,473.6% | -1,846.8% | -1,383.1% | -504.8% | -1,168.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -4.9% | -240.0% | -9,525.3% | -0.1% | – | – | – | – | – | – | -71.7% | – | – | – | – | – | – | -2,434.0% | -2,469.3% | -1,880.6% | -1,359.2% | -553.2% | -1,192.5% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.